Flagship-backed microbiome startup raises $98M to bring three drugs to clinic

Less than eight months after it emerged from stealth, Flagship Pioneering startup Senda Bioscience has raised another $98 million, and it’s planning on advancing its three lead programs into clinical trials by the end of next year.